Eurofins
The Analyst II, Analytical Development - Biologics role supports technology transfer, method development, qualification, and validation activities within the biopharmaceutical analytics group. The position involves planning and executing experimental work to generate data and prepare technical reports for early-stage research, preclinical development, or late-stage CMC programs. This role contributes to analytical strategies for cutting-edge biologic programs and fosters cross-functional collaboration to drive project objectives.
Headquarters
Luxembourg, Luxembourg, Luxembourg
Company Size
10001+ employees
Founded
1987
Eurofins Scientific is a global leader in laboratory testing and contract research, specializing in food, environmental, pharmaceutical product testing and agroscience CRO services. The group comprises more than 1,000 independent companies (over 950 laboratories) across 59 countries with over 65,000 staff and offers more than 200,000 analytical methods. Eurofins provides analytical testing, quality assurance and research services to support product safety, regulatory compliance and R&D. Clients choose Eurofins for its technical expertise, wide methodological coverage and extensive international laboratory network.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eurofins.
46% below the average for this role
Director, Analytical Sciences
Spyre Therapeutics
Senior Scientist I/II
AbbVie
Analytical Development Senior Research Associate
Vertex
Senior Scientist, Biologics Process Analytical Method Development
BioLife Plasma Services
Scientist I, Analytical Development and Quality Control
kaileratherapeutics
Advisor/Senior Advisor, Analytical Chemistry -Antibody-Drug Conjugates
Eli Lilly and Company